AusPAR: Adalimumab (rch)

Australian Public Assessment Report

AusPAR

AusPAR: Adalimumab (rch) [PDF, 780.73 KB]

AusPAR: Adalimumab (rch) [Word, 1.26 MB]

Attachment: Product Information: Adalimumab (rch) [PDF, 453.21 KB]

Attachment: Product Information: Adalimumab (rch) [Word, 657 KB]

Attachment: Extract from the Clinical Evaluation Report: Adalumumab [PDF, 1.49 MB]

Attachment: Extract from the Clinical Evaluation Report: Adalumumab (rch) [Word, 2.8 MB]

Device/Product Name

Humira

Active ingredients

Adalimumab (rch)

AusPAR Date

25 October 2013

Published

4 December 2013

Submission Number

PM-2012-01954-3-1

Submission Type

Extension of indications

Decision

Approved